Electroacupuncture Treatment of Peripheral Neuropathy After Taxane Chemotherapy for Breast Cancer
Electroacupuncture treatment of peripheral neuropathy after taxane chemotherapy for breast cancer
Trial Details
- NCT ID
- NCT06772935
- Phase
- NA
- Sponsor
- Affiliated Hospital of Qinghai University
- Status
- RECRUITING
- Cancer Type
- Breast Cancer
- Interventions
- Locations (sample)
- Xining, Qinghai, China|36.62554,101.75739
Key Eligibility Criteria
- Breast cancer patients diagnosed by pathology;
- EOOG score is 0 or 1;
- The age range for enrollment is between 18 and 75 years old; ④ Accept chemotherapy regimens based on taxane drugs (alone or in combination);
- ⑤ Previously received taxane chemotherapy for more than 6 months;
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →